Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
Go back to Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal| Alpine Management Systems, Inc. (NASDAQ: ALPN) | Delayed: 64.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.97 | 52 Week High | $0.00 | |||
| Open | $43.88 | 52 Week Low | $2156.81 | |||
| Day High | $64.97 | P/E | N/A | |||
| Day Low | $64.97 | EPS | $0.00 | |||
| Volume | 6,065 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 515.43 +0.80 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $514.63 | 52 Week High | $134.71 | |||
| Open | $513.80 | 52 Week Low | $73.31 | |||
| Day High | $517.95 | P/E | N/A | |||
| Day Low | $511.90 | EPS | $-1.98 | |||
| Volume | 40,583 | |||||
